X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (39) 39
index medicus (31) 31
hematology (30) 30
male (29) 29
female (26) 26
middle aged (22) 22
adult (21) 21
aged (21) 21
life sciences (16) 16
chronic myeloid leukemia (14) 14
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (14) 14
oncology (14) 14
leukemia (13) 13
aged, 80 and over (12) 12
cancer (11) 11
chronic myeloid-leukemia (10) 10
imatinib mesylate (10) 10
treatment outcome (10) 10
antineoplastic agents - therapeutic use (9) 9
follow-up studies (9) 9
prognosis (9) 9
benzamides (8) 8
chemistry (8) 8
dasatinib (8) 8
metallurgy (8) 8
organic chemistry (8) 8
patients (8) 8
therapy (8) 8
young adult (8) 8
adolescent (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
drug resistance, neoplasm (7) 7
pyrimidines - therapeutic use (7) 7
survival rate (7) 7
tyrosine (7) 7
antineoplastic agents (6) 6
chronic myelogenous leukemia (6) 6
cml (6) 6
fusion proteins, bcr-abl - genetics (6) 6
imatinib (6) 6
leukemia, myelogenous, chronic, bcr-abl positive - genetics (6) 6
leukemia, myeloid, chronic-phase - drug therapy (6) 6
pyrimidines - adverse effects (6) 6
retrospective studies (6) 6
culture media (5) 5
diagnosis (5) 5
disease-free survival (5) 5
human health and pathology (5) 5
interferon-alpha (5) 5
molecular response (5) 5
myeloid leukemia (5) 5
nilotinib (5) 5
piperazines - therapeutic use (5) 5
protein kinase inhibitors - therapeutic use (5) 5
pyrimidines - administration & dosage (5) 5
survival (5) 5
[ sdv.can ] life sciences [q-bio]/cancer (4) 4
acute myeloid-leukemia (4) 4
antimitotic agents (4) 4
antineoplastic agents - administration & dosage (4) 4
antineoplastic agents - adverse effects (4) 4
beer (4) 4
biochemistry (4) 4
child (4) 4
compositions or test papers therefor (4) 4
compositions thereof (4) 4
condition-responsive control in microbiological orenzymological processes (4) 4
cytarabine - administration & dosage (4) 4
drug resistance (4) 4
efficacy (4) 4
enzymology (4) 4
flow cytometry (4) 4
france (4) 4
hematology, oncology and palliative medicine (4) 4
hemic and lymphatic diseases (4) 4
heterocyclic compounds (4) 4
human necessities (4) 4
hygiene (4) 4
investigating or analysing materials by determining theirchemical or physical properties (4) 4
kaplan-meier estimate (4) 4
measuring (4) 4
measuring or testing processes involving enzymes, nucleicacids or microorganisms (4) 4
medical or veterinary science (4) 4
medicine, general & internal (4) 4
microbiology (4) 4
microorganisms or enzymes (4) 4
mutation or genetic engineering (4) 4
myeloproliferative neoplasms (4) 4
peptides (4) 4
physics (4) 4
piperazines - administration & dosage (4) 4
piperazines - adverse effects (4) 4
preparations for medical, dental, or toilet purposes (4) 4
processes of preparing such compositions (4) 4
propagating, preserving or maintaining microorganisms (4) 4
protein kinase inhibitors - administration & dosage (4) 4
protein-tyrosine kinase (4) 4
recommendations (4) 4
recurrence (4) 4
relapse (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2014, Volume 32, Issue 5, pp. 424 - 430
Journal Article
Cancer, ISSN 0008-543X, 05/2017, Volume 123, Issue 10, pp. 1791 - 1799
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 11/2017, Volume 92, Issue 11, pp. 1214 - 1223
Journal Article
British journal of haematology, ISSN 0007-1048, 07/2019
The effectiveness of tyrosine kinase inhibitors (TKIs) has made it possible to consider treatment discontinuation in chronic myeloid leukaemia (CML) patients... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 1, pp. 104 - 110
Journal Article
Journal Article
Journal Article